PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies
PEGylated nanomedicines are known to induce infusion reactions (IRs) that in some cases can be life-threatening. Herein, we report a case study in which a patient with rare mediastinal and intracardiac IgG4-related sclerosing disease received 8 treatments of intravenously administered PEGylated lipo...
Main Authors: | Yaelle Bavli, Bing-Mae Chen, Steve R. Roffler, Marina A. Dobrovolskaia, Eldad Elnekave, Shifra Ash, Yechezkel Barenholz, Keren Turjeman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/3/558 |
Similar Items
-
PEGylated liposomes: immunological responses
by: Marwa Mohamed, et al.
Published: (2019-12-01) -
Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
by: Hiroshi Kiwada, et al.
Published: (2010-12-01) -
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
by: Barry W. Neun, et al.
Published: (2018-07-01) -
Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery
by: Yan Fang, et al.
Published: (2017-11-01) -
Biomarkers of PEGylated Liposomal Doxorubicin-Induced Hypersensitivity Reaction in Breast Cancer Patients Based on Metabolomics
by: Wei Zhuang, et al.
Published: (2022-04-01)